Cas 1182818-14-9,1-(3-fluorophenyl)-N-methylpropan-2-amine

1182818-14-9

Post Buying Request

Basic information

Product Name: 1-(3-fluorophenyl)-N-methylpropan-2-amine
Synonyms: 1-(3-fluorophenyl)-N-methylpropan-2-amine
CAS NO:1182818-14-9
Molecular Formula:
Molecular Weight: 167.226
EINECS: N/A
Product Categories: N/A
Mol File: 1182818-14-9.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-(3-fluorophenyl)-N-methylpropan-2-amine(CAS DataBase Reference)
NIST Chemistry Reference: 1-(3-fluorophenyl)-N-methylpropan-2-amine(1182818-14-9)
EPA Substance Registry System: 1-(3-fluorophenyl)-N-methylpropan-2-amine(1182818-14-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1182818-14-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1182818-14-9 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

1182818-14-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1182818-14-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,2,8,1 and 8 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1182818-14:
(9*1)+(8*1)+(7*8)+(6*2)+(5*8)+(4*1)+(3*8)+(2*1)+(1*4)=159
159 % 10 = 9
So 1182818-14-9 is a valid CAS Registry Number.

1182818-14-9Upstream product

1737-19-5 (3-fluorophenyl)acetone

1182818-14-9Downstream Products

1182818-14-9Relevant articles and documents

PYRIDONE COMPOUND

-

Page/Page column 31, (2011/04/24)

[Problems] A useful compound which can be used as a pharmaceutical, in particular, an agent for treating peripheral arterial occlusive disease is provided. [Means for Solution] The present inventors have conducted extensive studies on EP4 receptor agonist